Company intelligence / Profile preview

Cearna Inc.

San Diego, California, United Statesactivmend.com ↗

Ownership: Private
Employees: ~5
Development stage: Commercial

Overview

The company has conducted clinical trials to test their arnica-based formulations for reducing bruising. Two trials were noted: one studying the effects of Arnica Montana and Ledum Palustre formulation on mechanically induced bruising, and another focused on developing a bruise scale in healthy volunteers.

Therapeutic areas: OtherPsychiatryDermatology
Modalities: Topical solutionsGel patches
Industry: Biotech

Drug pipeline

2 assets

ActivMend

Commercial

Indications: Bruising, Swelling, Pain, Soft tissue injury

1 more asset in the full pipeline.

Request access →

Partnerships

Allergan/Abbvie (licensed OcuMend in 2019)

Beyond the preview

Go deeper on Cearna Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cearna Inc..

Explore the full profile